Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Arquitos Capital Management Steven Kiel | “United Therapeutics is discussed strictly as Liquidia's key competitor and the opposing party in critical patent litigation. Its market multiple is used to value Liquidia, and its patent forms the basis of the ongoing legal dispute.” | BULL | Q1 2026 Apr 30, 2026 | View Pitch |
Polaris Global Equity Bernard Horn | “United Therapeutics climbed on record third quarter 2025 results, good uptake on Tyvaso regardless of generic competition and promising Tyvaso clinical trial results for idiopathic pulmonary fibrosis. UTHR also conducted the first successful UKidney transplant, generating excitement about its organ manufacturing firm. These achievements underscored both near-term execution and long-term optionality. Investor sentiment improved as growth proved resilient. BSD Analysis: United Therapeutics is a biotech that behaves like an industrial company, which is exactly why it works. Its pulmonary hypertension franchise throws off enormous, durable cash flow. Pipeline investments are self-funded, not dependent on capital markets. Investors worry about concentration risk, but lifecycle extensions and new indications mitigate it. Management prioritizes capital returns alongside R&D, a rare combination in biotech. The organ manufacturing ambition adds long-dated optionality without pressuring the core business. Execution has been consistently conservative and effective. This is biotech without existential drama. Cash flow buys patience.” | BULL | Q4 2025 Dec 31, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
